Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Ukraine
World Economic Forum (WEF)
Davos
COVID-19
China
Quadrilateral Security Dialogue
Omicron variant
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
World

European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds

European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
Written by Ramya Patelkhana
Jul 24, 2021, 11:23 am 3 min read
European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
Credits:
European Medicines Agency has recommended authorizing Moderna’s coronavirus vaccine for children aged 12-17 years

The European drug regulator on Friday recommended approving Moderna's coronavirus vaccine, called Spikevax, for use in children aged 12-17 years, making it the second vaccine to be authorized for this age group in the region. The European Medicines Agency (EMA) said a study involving over 3,700 children aged 12-17 years showed Spikevax triggered immune responses similar to those in young adults. Here's more.

The EMA
This approval comes two months after Pfizer-BioNTech's jab was authorized

Talking about the study, the Amsterdam-based European drug regulator stated, "The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above." Notably, the decision to recommend authorization of the Moderna vaccine comes nearly two months after the Pfizer-BioNTech vaccine was approved for adolescents by the EMA in May.

The study
Antibody response similar to young adults seen in 12-17-year-olds

The EMA said Spikevax's effects were studied among a total of 3,732 children aged 12-17 years. It said the Moderna vaccine produced an antibody response similar to what was seen in young adults aged 18-25 years. "The study showed that Spikevax produced a comparable antibody response in 12- to 17-year-olds to that seen in young adults aged 18 to 25 years," the EMA said.

Side effects
None of those administered Spikevax infected with COVID-19: Study

The study also showed none of the participants who were administered Spikevax was infected with COVID-19; four cases were seen in the group that received dummy shots. The most common side effects observed—including pain/swelling at the injection site, fatigue, headache, nausea, vomiting, and fever—were similar to those seen in adults. The Moderna vaccine is required to be given in two doses, four weeks apart.

Vaccination
Moderna vaccine now awaits formal approval by the European Commission

As the EMA recommended authorizing Spikevax for those aged 12-17 years, it now needs to receive formal approval by the European Commission to be administered to this age group in the European Union (EU) region. The EU Thursday said 200 million Europeans have so far been fully vaccinated—more than half the population, which is still short of its 70% target set for the summer.

Information
US considering whether Moderna vaccine can be used in adolescents

Notably, this is the first time that the Moderna vaccine has been approved by any drug regulator for use in those aged 12-17 years. Even the US Food and Drug Administration (FDA) is still studying whether its use can be extended to this age group.

Details
Moderna, Pfizer now testing their vaccines in even younger children

However, the American and European regulators have earlier warned the Moderna and Pfizer vaccines appear linked to extremely rare reactions, such as chest pain and heart inflammation, in teens and young adults. Meanwhile, both Moderna and Pfizer have already started testing their vaccines in even younger children—from those aged 11 years to six-month-old infants as well.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Latest
Europe
Coronavirus
COVID-19
COVID-19 Vaccine
Related
Latest
Pagani Huayra NC one-off supercar debuts with 830hp V12 engine
Pagani Huayra NC one-off supercar debuts with 830hp V12 engine Auto
5 foreign destinations to visit from India on a budget
5 foreign destinations to visit from India on a budget Lifestyle
Happy birthday Karan Johar: Here's what makes him a gamechanger
Happy birthday Karan Johar: Here's what makes him a gamechanger Entertainment
KOMAKI LY, DT 3000 EVs launched in India: Check features
KOMAKI LY, DT 3000 EVs launched in India: Check features Auto
Renaming district: Violent protesters in Andhra set minister's house ablaze
Renaming district: Violent protesters in Andhra set minister's house ablaze India
Europe
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus
Monkeypox: Maharashtra, Tamil Nadu, Rajasthan prepare to fight against virus India
Monkeypox spreads tentacles: US, Canada, Spain, and Portugal confirm cases
Monkeypox spreads tentacles: US, Canada, Spain, and Portugal confirm cases World
Russia defending 'motherland' in Ukraine, says Putin on Victory Day
Russia defending 'motherland' in Ukraine, says Putin on Victory Day World
Paris meet with Macron concludes PM Modi's Europe tour
Paris meet with Macron concludes PM Modi's Europe tour World
India wants Russian crude oil for less than $70/barrel: Report
India wants Russian crude oil for less than $70/barrel: Report Business
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19
COVID-19: India logs 1,675 fresh cases, 31 more deaths
COVID-19: India logs 1,675 fresh cases, 31 more deaths India
Pandemic created a billionaire every 30 hours: Oxfam at Davos
Pandemic created a billionaire every 30 hours: Oxfam at Davos World
First cases of new Omicron subvariants detected in India
First cases of new Omicron subvariants detected in India India
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries World
COVID-19: India reports 2,022 fresh cases, 46 more deaths
COVID-19: India reports 2,022 fresh cases, 46 more deaths India
More News
COVID-19 Vaccine
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
More News
Related
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
EU body says it didn't receive application for Covishield approval
EU body says it didn't receive application for Covishield approval India
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022